Work

Real life single centre experience with tofacitinib: Characteristics of treatment response

Year: 2024

Type: conference-paper

Abstract: Introduction: Tofacitinib was recently approved for juvenile idiopathic arthritis (JIA). To date only limited longitudinal ‚real-life‘ data was reported. We describe our experience including analyses if treatment response had associations to pretreatment or time of start. Methods: We [for full text, please go to the a.m. URL]

Source: German Medical Science (German Research Foundation)

DOI: 10.3205/24dgrh134

Authors: Gohar, Faekah, Wichmann, Katrin, Windschall, Daniel

Institutions: St. Josef-Stift Sendenhorst, Martin Luther University Halle-Wittenberg

Language: English

Topic: Autoimmune and Inflammatory Disorders Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W6927355618

FWCI:

Cites:

Cited by:

Related to: